Follow the 泰恩康 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 泰恩康 has logged 13 insider filings. Market capitalisation: €8.5bn. The latest transaction was disclosed on 6 June 2024 (Purchase). Among the most active insiders: 李挺. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
€2m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,666 of 29,064 companies
37.6
score / 100
Value
33
Quality
42
FCF yld-1.4%
Earn yld0.3%
EV/EBITDA·
ROE0.4%
Gross mgn54%
Net mgn4.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.